Moreover, ATF5 gene polymorphisms that appear to enhance activity at the ASNS promoter are linked to asparaginase treatment resistance in childhood acute lymphoblastic leukemia [8]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.